225 related articles for article (PubMed ID: 12543807)
1. Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium.
Carrascal MT; Mendoza L; Valcárcel M; Salado C; Egilegor E; Tellería N; Vidal-Vanaclocha F; Dinarello CA
Cancer Res; 2003 Jan; 63(2):491-7. PubMed ID: 12543807
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in the murine liver.
Mendoza L; Carrascal T; De Luca M; Fuentes AM; Salado C; Blanco J; Vidal-Vanaclocha F
Hepatology; 2001 Aug; 34(2):298-310. PubMed ID: 11481615
[TBL] [Abstract][Full Text] [Related]
3. Mannose receptor-mediated endothelial cell activation contributes to B16 melanoma cell adhesion and metastasis in liver.
Mendoza L; Olaso E; Anasagasti MJ; Fuentes AM; Vidal-Vanaclocha F
J Cell Physiol; 1998 Mar; 174(3):322-30. PubMed ID: 9462694
[TBL] [Abstract][Full Text] [Related]
4. Sinusoidal endothelium release of hydrogen peroxide enhances very late antigen-4-mediated melanoma cell adherence and tumor cytotoxicity during interleukin-1 promotion of hepatic melanoma metastasis in mice.
Anasagasti MJ; Alvarez A; Martin JJ; Mendoza L; Vidal-Vanaclocha F
Hepatology; 1997 Apr; 25(4):840-6. PubMed ID: 9096586
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases.
Vidal-Vanaclocha F; Amézaga C; Asumendi A; Kaplanski G; Dinarello CA
Cancer Res; 1994 May; 54(10):2667-72. PubMed ID: 8168095
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1-mediated H2O2 production by hepatic sinusoidal endothelium in response to B16 melanoma cell adhesion.
Anasagasti MJ; Alvarez A; Avivi C; Vidal-Vanaclocha F
J Cell Physiol; 1996 May; 167(2):314-23. PubMed ID: 8613473
[TBL] [Abstract][Full Text] [Related]
7. Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature.
Anasagasti MJ; Martin JJ; Mendoza L; Obrador E; Estrela JM; McCuskey RS; Vidal-Vanaclocha F
Hepatology; 1998 May; 27(5):1249-56. PubMed ID: 9581678
[TBL] [Abstract][Full Text] [Related]
8. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
Olaso E; Salado C; Egilegor E; Gutierrez V; Santisteban A; Sancho-Bru P; Friedman SL; Vidal-Vanaclocha F
Hepatology; 2003 Mar; 37(3):674-85. PubMed ID: 12601365
[TBL] [Abstract][Full Text] [Related]
9. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis.
Wang HH; McIntosh AR; Hasinoff BB; Rector ES; Ahmed N; Nance DM; Orr FW
Cancer Res; 2000 Oct; 60(20):5862-9. PubMed ID: 11059784
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cytokine-induced microvascular arrest of tumor cells by recombinant endostatin prevents experimental hepatic melanoma metastasis.
Mendoza L; Valcárcel M; Carrascal T; Egilegor E; Salado C; Sim BK; Vidal-Vanaclocha F
Cancer Res; 2004 Jan; 64(1):304-10. PubMed ID: 14729638
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
McKenzie RC; Oran A; Dinarello CA; Sauder DN
Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
[TBL] [Abstract][Full Text] [Related]
12. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells.
Khatib AM; Kontogiannea M; Fallavollita L; Jamison B; Meterissian S; Brodt P
Cancer Res; 1999 Mar; 59(6):1356-61. PubMed ID: 10096570
[TBL] [Abstract][Full Text] [Related]
13. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.
Vidal-Vanaclocha F; Fantuzzi G; Mendoza L; Fuentes AM; Anasagasti MJ; Martín J; Carrascal T; Walsh P; Reznikov LL; Kim SH; Novick D; Rubinstein M; Dinarello CA
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):734-9. PubMed ID: 10639148
[TBL] [Abstract][Full Text] [Related]
14. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
15. Multimodality imaging of IL-18--binding protein-Fc therapy of experimental lung metastasis.
Cao Q; Cai W; Niu G; He L; Chen X
Clin Cancer Res; 2008 Oct; 14(19):6137-45. PubMed ID: 18829492
[TBL] [Abstract][Full Text] [Related]
16. Effect induced by interleukin-1 on the behaviour of B16F10 melanoma cells.
De Galdeano AG; Boyano D; Cañavate L
Oncol Rep; 1999; 6(1):225-8. PubMed ID: 9864433
[TBL] [Abstract][Full Text] [Related]
17. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis.
Olaso E; Santisteban A; Bidaurrazaga J; Gressner AM; Rosenbaum J; Vidal-Vanaclocha F
Hepatology; 1997 Sep; 26(3):634-42. PubMed ID: 9303493
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice.
Melder RJ; Osborn BL; Riccobene T; Kanakaraj P; Wei P; Chen G; Stolow D; Halpern WG; Migone TS; Wang Q; Grzegorzewski KJ; Gallant G
Cancer Immunol Immunother; 2005 Jun; 54(6):535-47. PubMed ID: 15592670
[TBL] [Abstract][Full Text] [Related]
19. Suppression of growth and hepatic metastasis of murine B16FO melanoma cells by a novel nutrient mixture.
Roomi MW; Kalinovsky T; Roomi NW; Ivanov V; Rath M; Niedzwiecki A
Oncol Rep; 2008 Oct; 20(4):809-17. PubMed ID: 18813822
[TBL] [Abstract][Full Text] [Related]
20. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions.
Piantelli M; Rossi C; Iezzi M; La Sorda R; Iacobelli S; Alberti S; Natali PG
J Cell Physiol; 2006 Apr; 207(1):23-9. PubMed ID: 16222712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
